Gastroesophageal Reflux Disease clinical trials
39 active trials name this condition. Describe your situation to see which ones you may be eligible for.
By location
- Safety and Effectiveness of eGERD Device to Reduce Gastroesophageal Reflux Disease (GERD) Symptoms
- GERD in Children With Cystic Fibrosis
- Truncal Vagotomy in Patients Undergoing Revisional Sleeve Gastrectomy to Gastric Bypass
- A Study of Breath Testing for Small Intestinal Bacterial Overgrowth
- GERD Infant Feeding Therapeutics Trial (GIFT Trial)
- Mechanistic and Clinical Outcomes of a Surgical Innovation Aimed at Minimizing GERD Associated With VSG (INNOVATE-VSG)
- Anti-Reflux Endoscopic TX Using APC (AREA) in GERD Patients: (The AREA Study)
- Impact of Biosynthetic Mesh on Paraesophageal Hernia Repair
- Compassionate Use of Domperidone for Refractory Gastroparesis
- A Prospective, Single-Center Investigation of the da Vinci SP® Surgical System in Hepatopancreaticobiliary and Foregut Operations for Benign and Malignant Disease
- Mesh Vs Pledgets for Repair of Paraesophageal Hernia
- The Effect of the Reflux Band™ Upper Esophageal Sphincter (UES) Assist Device on Reflux for Lung Transplant Recipients
- Mechanisms Preventing Pharyngeal Reflux
- Evolution of the Chicago Classification: Bridging Physiology and Mechanics
- Utility of Mucosal Impedance Device in Chronic Esophageal Disorders:
- Patient Preferences for Barrett's Esophagus and Esophageal Cancer Screening Tests
- Efficacy Of Hiatal Closure For GERD
- Esophageal and Gastric Registry and Biorepository
- Endoscopic Bariatric Therapies (EBTs): A Retrospective and Prospective Multicenter Registry
- A Study of the Safety of Vonoprazan Exposure in Pregnant Women and Their Offspring
- Clinical Utility of WATS3D: A 5-Year Prospective Study
- Progression of Gastroesophageal Reflux Disease and Barrett's Esophagus and the Creation of a Barrett's Registry
- Indiana University Gastrointestinal Motility Diagnosis Registry
- Esophageal Cancer Risk Registry
- Randomized Controlled Crossover Trial of Postpyloric Feedings to Improve Pulmonary Outcomes in High-risk Preterm Infants
- Pilot Study for TCE Imaging of the Esophagus Using an OFDI Capsule With a Compact Imaging System
- Implementing Virtual Reality (VR) to Reduce Sedation
- Domperidone in Treating Patients With Gastrointestinal Disorders
- Oral Fosamprenavir + Sodium Alginate for GERD
- Antireflux Surgery Without Preoperative Esophageal Manometry
- PROPER-GERD: A Prospective Crossover Study to Evaluate Probe Placement Optimization for Reflux Testing in Women and Lower-BMI Patients
- A Comparison of Cosmos Rx Medication Adherence Platform vs. Pharmacy Fill Adherence Measures
- Developing and Testing Mobile Health Question Prompt List in Gastroesophageal Reflux Disease
- Targeting Hypervigilance and Autonomic Arousal: the Psycho-physiologic Model of Gastroesophageal Reflux Disease (GERD)
- Transoral Incisionless Fundoplication Database Repository (TIF)
- Assessment of Esophageal Epithelium Integrity With Use of a Novel Mucosal Impedance Device
- Study to Evaluate EnteroTracker® as a Sampling Method to Screen for Barrett's Esophagus/Esophageal Cancer
- Biomarkers of Airway Disease, Barrett's and Underdiagnosed Reflux Noninvasively (BADBURN)
- The Johns Hopkins Heartburn Center Registry
Guides for people searching for a trial
- Why people get turned down — and what to do nextWhat eligibility criteria are for, what keeps people out, and where to go when the first door closes.
- How your biomarkers decide which trials you qualify forEGFR, HER2, BRAF, PD-L1 and the rest — what they are and why they increasingly gate access.
- How to search for a trial without losing your mindWhere to look, what to gather first, and how to read what you find.
- What Phase 1, 2 and 3 actually mean for youWhat each phase is testing, and how to weigh an early-phase trial against a later one.
- 10 questions to ask before you say yesTreatment, time, cost, safety and your rights. Worth bringing to a screening visit.
- You matched with a trial. What happens now?Phone screens, the screening visit, informed consent, and day one.
Showing active trials that list “Gastroesophageal Reflux Disease” as a condition. Eligibility shown on each trial is an estimate — the trial's study team makes the final decision.